Vera Therapeutics, Inc.
VERA
$34.46
-$0.82-2.32%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 52.41M | 39.12M | 34.90M | 27.46M | 21.95M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 112.49M | 125.13M | 94.21M | 83.93M | 80.14M |
| Operating Income | -112.49M | -125.13M | -94.21M | -83.93M | -80.14M |
| Income Before Tax | -109.47M | -121.03M | -91.10M | -80.29M | -76.53M |
| Income Tax Expenses | -- | -- | 1.00K | -- | -- |
| Earnings from Continuing Operations | -109.47M | -121.03M | -91.10M | -80.29M | -76.53M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -109.47M | -121.03M | -91.10M | -80.29M | -76.53M |
| EBIT | -112.49M | -125.13M | -94.21M | -83.93M | -80.14M |
| EBITDA | -112.36M | -124.99M | -94.07M | -83.80M | -80.02M |
| EPS Basic | -1.52 | -1.69 | -1.39 | -1.26 | -1.20 |
| Normalized Basic EPS | -0.95 | -1.05 | -0.87 | -0.79 | -0.75 |
| EPS Diluted | -1.52 | -1.69 | -1.39 | -1.26 | -1.20 |
| Normalized Diluted EPS | -0.95 | -1.05 | -0.87 | -0.79 | -0.75 |
| Average Basic Shares Outstanding | 71.84M | 71.48M | 65.63M | 63.85M | 63.79M |
| Average Diluted Shares Outstanding | 71.84M | 71.48M | 65.63M | 63.85M | 63.79M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |